Covers a range of topics, including clinical assessment, pathophysiology, the link between dry eye and system disease, and the use of FDA and off-label products as treatment options for dry eye diseases.
Includes a section devoted to the presence of dry eye disease in specific populations, including patients presenting with other ocular conditions, systemic pain conditions, graft-versus-host disease, Sjögren's syndrome, and meibomian gland dysfunction.
Addresses the challenges associated with treating ocular pain not responsive to traditional dry eye disease treatments.
Features concise chapters from a team of international chapter authors, providing global perspectives on this common disorder.
Consolidates today's available information on this timely topic into a single, convenient resource